Dr. MacDonald explains how an ASO(antisense oligonucleotide)-based gene therapy works on Leber’s Congenital Amaurosis (LCA) 10 patients with a CEP290 gene deep intronic mutation (c.2991+1655 A>G).
Dr. MacDonald explains how an ASO(antisense oligonucleotide)-based gene therapy works on Leber’s Congenital Amaurosis (LCA) 10 patients with a CEP290 gene deep intronic mutation (c.2991+1655 A>G).